Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
11.62
-0.96 (-7.63%)
Mar 31, 2025, 1:21 PM EDT - Market open

Outset Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
113.69130.38115.38102.649.94
Upgrade
Revenue Growth (YoY)
-12.80%13.00%12.45%105.47%231.18%
Upgrade
Cost of Revenue
74.55101.2597.5494.9962.97
Upgrade
Gross Profit
39.1429.1317.837.61-13.04
Upgrade
Selling, General & Admin
110.67139.8130101.3975.58
Upgrade
Research & Development
36.2956.5748.8636.7428.85
Upgrade
Operating Expenses
146.96196.37178.85138.13104.43
Upgrade
Operating Income
-107.82-167.24-161.02-130.52-117.47
Upgrade
Interest Expense
-23.87-12.68-3.57-1.72-2.89
Upgrade
Interest & Investment Income
9.7610.173.290.50.53
Upgrade
Other Non Operating Income (Expenses)
-----0.09
Upgrade
EBT Excluding Unusual Items
-121.93-169.74-161.29-131.74-119.93
Upgrade
Merger & Restructuring Charges
-5.56-2.53---
Upgrade
Other Unusual Items
---1.37--1.57
Upgrade
Pretax Income
-127.49-172.27-162.66-131.74-121.49
Upgrade
Income Tax Expense
0.490.520.30.2-
Upgrade
Earnings From Continuing Operations
-127.98-172.8-162.96-131.94-121.49
Upgrade
Net Income
-127.98-172.8-162.96-131.94-121.49
Upgrade
Preferred Dividends & Other Adjustments
-----42.17
Upgrade
Net Income to Common
-127.98-172.8-162.96-131.94-79.32
Upgrade
Shares Outstanding (Basic)
33331
Upgrade
Shares Outstanding (Diluted)
33331
Upgrade
Shares Change (YoY)
4.76%2.96%5.64%178.69%1806.53%
Upgrade
EPS (Basic)
-36.95-52.27-50.75-43.41-72.74
Upgrade
EPS (Diluted)
-36.95-52.27-50.75-43.41-72.74
Upgrade
Free Cash Flow
-117.22-134.81-154.05-133.37-108.09
Upgrade
Free Cash Flow Per Share
-33.84-40.78-47.98-43.88-99.12
Upgrade
Gross Margin
34.43%22.34%15.46%7.41%-26.11%
Upgrade
Operating Margin
-94.84%-128.27%-139.56%-127.21%-235.24%
Upgrade
Profit Margin
-112.57%-132.54%-141.24%-128.59%-158.85%
Upgrade
Free Cash Flow Margin
-103.10%-103.40%-133.53%-129.99%-216.47%
Upgrade
EBITDA
-102.09-161.43-155.85-125.36-114.31
Upgrade
EBITDA Margin
-89.80%-123.82%-135.08%-122.18%-228.91%
Upgrade
D&A For EBITDA
5.735.815.175.163.16
Upgrade
EBIT
-107.82-167.24-161.02-130.52-117.47
Upgrade
EBIT Margin
-94.84%-128.27%-139.56%-127.21%-235.24%
Upgrade
Revenue as Reported
113.69130.38115.38102.649.94
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q